Anthropic launches Claude Science workbench for researchers
8 reported
Anthropic introduced Claude Science on Tuesday, an AI workbench designed to give scientists a single environment for computational research, according to a TechCrunch report. The company stated that Claude Science is not a new AI model or a more capable model for biology, but runs the same Claude models already available to everyone, including Claude Opus 4.8, with no special access. The workbench builds on Anthropic’s October 2025 launch of Claude for Life Sciences and fits into the company’s broader push to be more than a model provider, similar to how Claude Code serves as an operating layer for software development. The system connects to more than 60 scientific databases, includes prebuilt toolkits for fields like genomics and protein structure, and features a fact-checker AI to double-check citations and calculations before publication. Early users include Allen Institute neuroscientist Jérôme Lecoq and Stephen Francis’s group at the UCSF Brain Tumor Center. Claude Science is available in beta to Pro, Max, Team, and Enterprise subscribers, and Anthropic will support up to 50 projects with up to $30,000 in credits for postdoctoral and graduate work.
What’s reported
Anthropic introduced Claude Science on Tuesday, June 30, 2026.
Claude Science is an AI workbench, not a new AI model or a more capable model for biology.
It runs the same Claude models already available, including Claude Opus 4.8, with no special access.
The workbench connects to more than 60 scientific databases and includes prebuilt toolkits for genomics, protein structure, and chemistry.
A separate fact-checker AI double-checks citations and calculations before publication.
Early users include Allen Institute neuroscientist Jérôme Lecoq and Stephen Francis’s group at UCSF Brain Tumor Center.
Claude Science is available in beta to Pro, Max, Team, and Enterprise subscribers.
Anthropic will support up to 50 projects with up to $30,000 in credits, with applications open through July 15, 2026.
Key figures
Jérôme Lecoq, Allen Institute neuroscientist
Stephen Francis, UCSF Brain Tumor Center group leader
Anthropic (company)
OpenAI (company)
Google DeepMind (company)
Novo Nordisk (company)
Allen Institute (organization)
Sources: TechCrunch
